|
| 36689660 | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | Proc Natl Acad Sci U S A | 2023 |
| 37968881 | Report From a Multidisciplinary Symposium on the Future of Living Kidney Donor Transplantation. | Prog Transplant | 2023 |
| 37450595 | RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy. | Sci Adv | 2023 |
| 37149146 | The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling. | J Biol Chem | 2023 |
| 37245145 | RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. | J Invest Dermatol | 2023 |
| 37268708 | Reduced dynamic complexity allows structure elucidation of an excited state of KRAS<sup>G13D</sup>. | Commun Biol | 2023 |
| 34686998 | NMR <sup>1</sup>H, <sup>13</sup>C, <sup>15</sup>N backbone resonance assignments of the T35S and oncogenic T35S/Q61L mutants of human KRAS4b in the active, GppNHp-bound conformation. | Biomol NMR Assign | 2022 |
| 35613620 | ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1. | Mol Cell | 2022 |
| 35467524 | Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs. | Elife | 2022 |
| 35831509 | Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex. | Nature | 2022 |
| 35690519 | Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains. | Value Health | 2022 |
| 35561303 | More to the RAS Story: KRAS<sup>G12C</sup> Inhibition, Resistance Mechanisms, and Moving Beyond KRAS<sup>G12C</sup>. | Am Soc Clin Oncol Educ Book | 2022 |
| 36144235 | Novel Regulators of Macropinocytosis-Dependent Growth Revealed by Informer Set Library Screening in Pancreatic Cancer Cells. | Metabolites | 2022 |
| 35904492 | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | Cancer Discov | 2022 |
| 36175670 | Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome. | Nat Struct Mol Biol | 2022 |
| 35961479 | Workload for infection prevention and control teams in preventing nosocomial tuberculosis: an underestimated burden. | J Hosp Infect | 2022 |
| 35046096 | RAS at 40: Update from the RAS Initiative. | Cancer Discov | 2022 |
| 35101227 | A brief history of RAS and the RAS Initiative. | Adv Cancer Res | 2022 |
| 34983849 | Machine learning-driven multiscale modeling reveals lipid-dependent dynamics of RAS signaling proteins. | Proc Natl Acad Sci U S A | 2022 |
| 35091470 | Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors. | Proc Natl Acad Sci U S A | 2022 |
| 35213144 | Insights into the Cross Talk between Effector and Allosteric Lobes of KRAS from Methyl Conformational Dynamics. | J Am Chem Soc | 2022 |
| 34872108 | Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models. | Blood Adv | 2022 |
| 32822265 | Evidence-Based Physical Examination for the Diagnosis of Subscapularis Tears: A Systematic Review. | Sports Health | 2021 |
| 33541252 | Promoting Ethical Payment in Human Infection Challenge Studies. | Am J Bioeth | 2021 |
| 33846634 | Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. | Nat Genet | 2021 |
| 33870211 | The Metabolic Landscape of RAS-Driven Cancers from biology to therapy. | Nat Cancer | 2021 |
| 33896272 | Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition. | SLAS Discov | 2021 |
| 33837738 | Correction: DoMY-Seq: A yeast two-hybrid-based technique for precision mapping of protein-protein interaction motifs. | J Biol Chem | 2021 |
| 33749935 | Estimated impact of novel coronavirus-19 and transplant center inactivity on end-stage renal disease-related patient mortality in the United States. | Clin Transplant | 2021 |
| 33689566 | Plumbing the Depths of Ethical Payment for Research Participation. | Am J Bioeth | 2021 |
| 33608534 | KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation. | Nat Commun | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 34380736 | RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity. | Proc Natl Acad Sci U S A | 2021 |
| 34514432 | Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis. | Blood Cancer Discov | 2021 |
| 33990767 | RAS-targeted therapies. | Nat Rev Drug Discov | 2021 |
| 33988344 | Cost Structures of US Organ Procurement Organizations. | Transplantation | 2021 |
| 34237269 | The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression. | Curr Biol | 2021 |
| 34307350 | A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness. | Front Cell Dev Biol | 2021 |
| 34330832 | UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. | Proc Natl Acad Sci U S A | 2021 |
| 33271212 | Reducing the Shortage of Transplant Kidneys: A Lost Opportunity for the US Health Resources and Services Administration (HRSA). | Am J Kidney Dis | 2021 |
| 33410398 | DoMY-Seq: A yeast two-hybrid-based technique for precision mapping of protein-protein interaction motifs. | J Biol Chem | 2021 |
| 32603749 | Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC. | J Invest Dermatol | 2021 |
| 32341551 | The duality of human oncoproteins: drivers of cancer and congenital disorders. | Nat Rev Cancer | 2020 |
| 33872193 | SPRED proteins and their roles in signal transduction, development, and malignancy. | Genes Dev | 2020 |
| 31667990 | The cost of procuring deceased donor kidneys: Evidence from OPO cost reports 2013-2017. | Am J Transplant | 2020 |
| 31958057 | Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior. | Elife | 2020 |
| 31836666 | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | J Biol Chem | 2020 |
| 32047043 | The small molecule BI-2852 induces a nonfunctional dimer of KRAS. | Proc Natl Acad Sci U S A | 2020 |
| 31951561 | Sticking it to KRAS: Covalent Inhibitors Enter the Clinic. | Cancer Cell | 2020 |
| 31772119 | Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study. | Clin Cancer Res | 2020 |